FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088203721> ?p ?o ?g. }

• W2088203721 endingPage "12" @default.
• W2088203721 startingPage "1" @default.
• W2088203721 abstract "The hypothesis that heparin-coated perfusion circuits reduce thrombin formation and activity; fibrinolysis; and platelet, complement, and neutrophil activation was tested in 20 consecutive, randomized adults who had cardiopulmonary bypass. Twenty identical perfusion systems were used; in 10, all blood-contacting surfaces were coated with partially degraded heparin (Carmeda process; Medtronic Cardiopulmonary, Anaheim, Calif.). All patients received a 300 U/kg dose of heparin. Activated clotting times were maintained longer than 400 seconds. Cardiopulmonary bypass lasted 36 to 244 minutes. Blood samples for platelet count, platelet response to adenosine diphosphate, plasma β-thromboglobulin, inactivated complement 3b, neutrophil elastase, fibrinopeptide A, prothrombin fragment F1.2, thrombin-antithrombin complex, tissue plasminogen activator, plasminogen activator inhibitor-1, plasmin α2-antiplasmin complex, and D-dimer were obtained at these times: after heparin was given, 5 and 30 minutes after cardiopulmonary bypass was started, within 5 minutes after bypass was stopped, and 15 minutes after protamine was given. After cardiopulmonary bypass, tubing segments were analyzed for surface-adsorbed antithrombin, fibrinogen, factor XII, and von Willebrand factor by radioimmunoassay. Heparin-coated circuits significantly (p < 0.001) reduced platelet adhesion and maintained platelet sensitivity to adenosine diphosphate (p = 0.015), but did not reduce release of β-thromboglobulin. There were no significant differences between groups at any time for fibrinopeptide A, prothrombin fragment F1.2, or thrombin-antithrombin complex or in the markers for fibrinolysis: D-dimer, tissue plasminogen activator, plasminogen activator inhibitor-1, and α2-antiplasmin complex. In both groups, concentrations of prothrombin fragment F1.2 and thrombin-antithrombin complex increased progressively and significantly during cardiopulmonary bypass and after protamine was given. Concentrations of D-dimer, α2-antiplasmin complex, and plasminogen activator inhibitor-1 also increased significantly during bypass in both groups. Fibrinopeptide A levels did not increase during bypass but in both groups increased significantly after protamine was given. No significant differences were observed between groups for levels of inactivated complement 3b or neutrophil elastase. Radioimmunoassay showed a significant increase in surface-adsorbed antithrombin on coated circuits but no significant differences between groups for other proteins. We conclude that heparin-coated circuits used with standard doses of systemic heparin reduce platelet adhesion and improve platelet function but do not produce a meaningful anticoagulant effect during clinical cardiopulmonary bypass. The data do not support the practice of reducing systemic heparin doses during cardiac operations with heparin-coated extracorporeal perfusion circuitry. (J THORAC CARDIOVASC SURG 1996;111:1-12)" @default.
• W2088203721 created "2016-06-24" @default.
• W2088203721 creator A5001263943 @default.
• W2088203721 creator A5018151758 @default.
• W2088203721 creator A5023230653 @default.
• W2088203721 creator A5024216881 @default.
• W2088203721 creator A5026238583 @default.
• W2088203721 creator A5035396310 @default.
• W2088203721 creator A5036296619 @default.
• W2088203721 creator A5061115846 @default.
• W2088203721 creator A5066669844 @default.
• W2088203721 creator A5067583799 @default.
• W2088203721 creator A5069143752 @default.
• W2088203721 creator A5077997436 @default.
• W2088203721 creator A5081586279 @default.
• W2088203721 creator A5088903937 @default.
• W2088203721 date "1996-01-01" @default.
• W2088203721 modified "2023-10-10" @default.
• W2088203721 title "Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass" @default.
• W2088203721 cites W118980958 @default.
• W2088203721 cites W133116715 @default.
• W2088203721 cites W1592226092 @default.
• W2088203721 cites W177712551 @default.
• W2088203721 cites W1936037930 @default.
• W2088203721 cites W1967125883 @default.
• W2088203721 cites W1971281960 @default.
• W2088203721 cites W1976356486 @default.
• W2088203721 cites W1976383656 @default.
• W2088203721 cites W1988095728 @default.
• W2088203721 cites W1989876068 @default.
• W2088203721 cites W2000007666 @default.
• W2088203721 cites W2000648658 @default.
• W2088203721 cites W2009147346 @default.
• W2088203721 cites W2022240776 @default.
• W2088203721 cites W2025673781 @default.
• W2088203721 cites W2046613475 @default.
• W2088203721 cites W2065662560 @default.
• W2088203721 cites W2069068451 @default.
• W2088203721 cites W2071569782 @default.
• W2088203721 cites W2074781141 @default.
• W2088203721 cites W2075331103 @default.
• W2088203721 cites W2087653484 @default.
• W2088203721 cites W2095868407 @default.
• W2088203721 cites W2103356587 @default.
• W2088203721 cites W2112799238 @default.
• W2088203721 cites W2142076308 @default.
• W2088203721 cites W2157575769 @default.
• W2088203721 cites W2165453706 @default.
• W2088203721 cites W21802224 @default.
• W2088203721 cites W2319045997 @default.
• W2088203721 cites W2397641428 @default.
• W2088203721 cites W2398532163 @default.
• W2088203721 cites W2405208563 @default.
• W2088203721 cites W2406834449 @default.
• W2088203721 cites W2409330018 @default.
• W2088203721 cites W2413001277 @default.
• W2088203721 cites W2417030366 @default.
• W2088203721 cites W292647304 @default.
• W2088203721 cites W3111388598 @default.
• W2088203721 cites W31130990 @default.
• W2088203721 cites W4298189681 @default.
• W2088203721 cites W57471503 @default.
• W2088203721 doi "https://doi.org/10.1016/s0022-5223(96)70395-1" @default.
• W2088203721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8551753" @default.
• W2088203721 hasPublicationYear "1996" @default.
• W2088203721 type Work @default.
• W2088203721 sameAs 2088203721 @default.
• W2088203721 citedByCount "135" @default.
• W2088203721 countsByYear W20882037212013 @default.
• W2088203721 countsByYear W20882037212014 @default.
• W2088203721 countsByYear W20882037212015 @default.
• W2088203721 countsByYear W20882037212016 @default.
• W2088203721 countsByYear W20882037212018 @default.
• W2088203721 countsByYear W20882037212019 @default.
• W2088203721 countsByYear W20882037212020 @default.
• W2088203721 countsByYear W20882037212021 @default.
• W2088203721 countsByYear W20882037212022 @default.
• W2088203721 countsByYear W20882037212023 @default.
• W2088203721 crossrefType "journal-article" @default.
• W2088203721 hasAuthorship W2088203721A5001263943 @default.
• W2088203721 hasAuthorship W2088203721A5018151758 @default.
• W2088203721 hasAuthorship W2088203721A5023230653 @default.
• W2088203721 hasAuthorship W2088203721A5024216881 @default.
• W2088203721 hasAuthorship W2088203721A5026238583 @default.
• W2088203721 hasAuthorship W2088203721A5035396310 @default.
• W2088203721 hasAuthorship W2088203721A5036296619 @default.
• W2088203721 hasAuthorship W2088203721A5061115846 @default.
• W2088203721 hasAuthorship W2088203721A5066669844 @default.
• W2088203721 hasAuthorship W2088203721A5067583799 @default.
• W2088203721 hasAuthorship W2088203721A5069143752 @default.
• W2088203721 hasAuthorship W2088203721A5077997436 @default.
• W2088203721 hasAuthorship W2088203721A5081586279 @default.
• W2088203721 hasAuthorship W2088203721A5088903937 @default.
• W2088203721 hasBestOaLocation W20882037211 @default.
• W2088203721 hasConcept C126322002 @default.
• W2088203721 hasConcept C159973064 @default.
• W2088203721 hasConcept C203014093 @default.
• W2088203721 hasConcept C2776572282 @default.

• next